16-2831840-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145252.3(ZG16B):āc.200C>Gā(p.Ala67Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,613,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145252.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZG16B | NM_145252.3 | c.200C>G | p.Ala67Gly | missense_variant | 4/4 | ENST00000382280.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZG16B | ENST00000382280.8 | c.200C>G | p.Ala67Gly | missense_variant | 4/4 | 1 | NM_145252.3 | P1 | |
ZG16B | ENST00000572863.2 | c.200C>G | p.Ala67Gly | missense_variant | 3/3 | 2 | P1 | ||
ZG16B | ENST00000570670.6 | c.155+1044C>G | intron_variant | 3 | |||||
ZG16B | ENST00000573019.1 | n.452C>G | non_coding_transcript_exon_variant | 3/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249166Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135250
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461708Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727154
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.308C>G (p.A103G) alteration is located in exon 4 (coding exon 4) of the ZG16B gene. This alteration results from a C to G substitution at nucleotide position 308, causing the alanine (A) at amino acid position 103 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at